20697068

Source:http://linkedlifedata.com/resource/pubmed/id/20697068

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006142, umls-concept:C0017428, umls-concept:C0036667, umls-concept:C0279025, umls-concept:C0312418, umls-concept:C0918012
pubmed:issue	27
pubmed:dateCreated	2010-9-17
pubmed:databankReference	http://linkedlifedata.com/resource/pubmed/xref/GEO/GSE17700, http://linkedlifedata.com/resource/pubmed/xref/GEO/GSE17705
pubmed:abstractText	We hypothesize that measurement of gene expression related to estrogen receptor ? (ER; gene name ESR1) within a breast cancer sample represents intrinsic tumoral sensitivity to adjuvant endocrine therapy.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/1-R21 CA118156-01A1
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/20697068-20697070
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal, http://linkedlifedata.com/resource/pubmed/chemical/Aromatase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Receptor alpha, http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological, http://linkedlifedata.com/resource/pubmed/chemical/estrogen receptor alpha, human
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	1527-7755
pubmed:author	pubmed-author:AndreFabriceF, pubmed-author:BauernhoferThomasT, pubmed-author:BooserDaniel JDJ, pubmed-author:DaxenbichlerGuenterG, pubmed-author:DelalogeSuzetteS, pubmed-author:DesmedtChristineC, pubmed-author:DomontJulienJ, pubmed-author:HatzisChristosC, pubmed-author:HortobagyiGabriel NGN, pubmed-author:MarthChristianC, pubmed-author:PeintingerFlorentiaF, pubmed-author:PusztaiLajosL, pubmed-author:RegitnigPeterP, pubmed-author:SotiriouChristosC, pubmed-author:SymmansW FraserWF, pubmed-author:ValeroVicenteV
pubmed:issnType	Electronic
pubmed:day	20
pubmed:volume	28
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	4111-9
pubmed:dateRevised	2011-9-21
pubmed:meshHeading	pubmed-meshheading:20697068-Antineoplastic Agents, Hormonal, pubmed-meshheading:20697068-Aromatase Inhibitors, pubmed-meshheading:20697068-Breast Neoplasms, pubmed-meshheading:20697068-Chemotherapy, Adjuvant, pubmed-meshheading:20697068-Chi-Square Distribution, pubmed-meshheading:20697068-Disease-Free Survival, pubmed-meshheading:20697068-Estrogen Receptor alpha, pubmed-meshheading:20697068-Female, pubmed-meshheading:20697068-Gene Expression Profiling, pubmed-meshheading:20697068-Gene Expression Regulation, Neoplastic, pubmed-meshheading:20697068-Genomics, pubmed-meshheading:20697068-Humans, pubmed-meshheading:20697068-Middle Aged, pubmed-meshheading:20697068-Neoplasm Staging, pubmed-meshheading:20697068-Oligonucleotide Array Sequence Analysis, pubmed-meshheading:20697068-Patient Selection, pubmed-meshheading:20697068-Proportional Hazards Models, pubmed-meshheading:20697068-Risk Assessment, pubmed-meshheading:20697068-Risk Factors, pubmed-meshheading:20697068-Survival Analysis, pubmed-meshheading:20697068-Tamoxifen, pubmed-meshheading:20697068-Time Factors, pubmed-meshheading:20697068-Transcription, Genetic, pubmed-meshheading:20697068-Treatment Outcome, pubmed-meshheading:20697068-Tumor Markers, Biological
pubmed:year	2010
pubmed:articleTitle	Genomic index of sensitivity to endocrine therapy for breast cancer.
pubmed:affiliation	Department of Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. fsymmans@mdanderson.org
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural